Analysis group identifies potential drug to deal with SARS-CoV-2

Must read

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, remoted from a affected person. Picture captured and color-enhanced on the NIAID Built-in Analysis Facility (IRF) in Fort Detrick, Maryland. Credit score: Nationwide Institute of Allergy and Infectious Ailments, NIH

A federally accepted coronary heart remedy exhibits important effectiveness in interfering with SARS-CoV-2 entry into the human cell host, in accordance with a brand new research by a analysis group from Texas A&M College and The College of Texas Medical Department (UTMB).

The remedy bepridil, which fits by the commerce identify Vascor, is presently accepted by the U.S. Meals and Drug Administration (FDA) to deal with angina, a coronary heart situation.

The group’s leaders are Faculty of Science professor Wenshe Ray Liu, professor and holder of the Gradipore Chair within the Division of Chemistry at Texas A&M, and Chien-Te Kent Tseng, professor and director of the SARS/MERS/COVID-19 Laboratory at UTMB. Liu additionally holds joint college positions in Texas A&M’s faculties of drugs and agriculture and .

“Just one remedy is presently out there, Remdesivir, to supply restricted advantages to COVID-19 sufferers, and the virus might simply evade it,” Liu mentioned. “Discovering various medicines is crucial. Our group screened greater than 30 FDA/European Medicines Company accepted medicine for his or her capacity to inhibit SARS-COV-2’s entry into . The research discovered bepridil to supply probably the most potential for therapy of COVID-19. Because of this, we’re advocating for the intense consideration of utilizing bepridil in scientific exams associated to SARS-CoV-2.”

The Texas A&M-UTMB research is now out there on the web site of the peer-reviewed Proceedings of the Nationwide Academy of Sciences (PNAS) and is scheduled for print publication on March 9.

The group, which incorporates six different researchers from Texas A&M and 4 from UTMB, now plans to advance their work to animal fashions with a possible for scientific trials.

Follow the latest news on the coronavirus (COVID-19) outbreak

Extra data:
Erol C. Vatansever et al, Bepridil is potent in opposition to SARS-CoV-2 in vitro, Proceedings of the Nationwide Academy of Sciences (2021). DOI: 10.1073/pnas.2012201118

Analysis group identifies potential drug to deal with SARS-CoV-2 (2021, February 22)
retrieved 23 February 2021

This doc is topic to copyright. Aside from any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for data functions solely.

- Advertisement -

More articles

- Advertisement -

Latest article

A Swing and a Hit? Golf Beneficial in Parkinson’s Disease

Playing golf improves mobility and balance in Parkinson's disease (PD) better than tai chi, the gold standard exercise...

What a Difference a Year Makes: California Poised to Reopen

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. ...